1
|
Avin KG, Allen MR, Chen NX, Srinivasan S, O'Neill KD, Troutman AD, Mast G, Swallow EA, Brown MB, Wallace JM, Zimmers TA, Warden SJ, Moe SM. Voluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD). J Am Soc Nephrol 2019; 30:1898-1909. [PMID: 31501355 DOI: 10.1681/asn.2019040349] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Accepted: 06/16/2019] [Indexed: 01/27/2023] Open
Abstract
BACKGROUND Reduced bone and muscle health in individuals with CKD contributes to their higher rates of morbidity and mortality. METHODS We tested the hypothesis that voluntary wheel running would improve musculoskeletal health in a CKD rat model. Rats with spontaneous progressive cystic kidney disease (Cy/+ IU) and normal littermates (NL) were given access to a voluntary running wheel or standard cage conditions for 10 weeks starting at 25 weeks of age when the rats with kidney disease had reached stage 2-3 of CKD. We then measured the effects of wheel running on serum biochemistry, tissue weight, voluntary grip strength, maximal aerobic capacity (VO2max), body composition and bone micro-CT and mechanics. RESULTS Wheel running improved serum biochemistry with decreased creatinine, phosphorous, and parathyroid hormone in the rats with CKD. It improved muscle strength, increased time-to-fatigue (for VO2max), reduced cortical porosity and improved bone microarchitecture. The CKD rats with voluntary wheel access also had reduced kidney cystic weight and reduced left ventricular mass index. CONCLUSIONS Voluntary wheel running resulted in multiple beneficial systemic effects in rats with CKD and improved their physical function. Studies examining exercise interventions in patients with CKD are warranted.
Collapse
Affiliation(s)
- Keith G Avin
- Division of Nephrology and .,Department of Physical Therapy, Indiana University School of Health and Human Sciences, Indianapolis, Indiana; and.,Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana
| | - Matthew R Allen
- Division of Nephrology and.,Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana.,Departments of Medicine, Anatomy and Cell Biology, and
| | - Neal X Chen
- Division of Nephrology and.,Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana
| | - Shruthi Srinivasan
- Division of Nephrology and.,Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana
| | - Kalisha D O'Neill
- Division of Nephrology and.,Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana
| | - Ashley D Troutman
- Department of Physical Therapy, Indiana University School of Health and Human Sciences, Indianapolis, Indiana; and
| | - Garrison Mast
- Departments of Medicine, Anatomy and Cell Biology, and
| | | | - Mary Beth Brown
- Department of Physical Therapy, Indiana University School of Health and Human Sciences, Indianapolis, Indiana; and
| | - Joseph M Wallace
- Division of Nephrology and.,Departments of Medicine, Anatomy and Cell Biology, and
| | - Teresa A Zimmers
- Medicine and General Surgery, Indiana University School of Medicine, Indianapolis, Indiana
| | - Stuart J Warden
- Department of Physical Therapy, Indiana University School of Health and Human Sciences, Indianapolis, Indiana; and.,Departments of Medicine, Anatomy and Cell Biology, and
| | - Sharon M Moe
- Division of Nephrology and.,Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana.,Departments of Medicine, Anatomy and Cell Biology, and
| |
Collapse
|
2
|
Fibroblast growth factor 21 plays an inhibitory role in vascular calcification in vitro through OPG/RANKL system. Biochem Biophys Res Commun 2017; 491:578-586. [PMID: 28774557 DOI: 10.1016/j.bbrc.2017.07.160] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 07/28/2017] [Indexed: 01/08/2023]
Abstract
Vascular calcification is prevalent and associated with adverse outcome without available therapy. The benefits of fibroblast growth factor (FGF)-21 on metabolism and atherosclerosis make it a promising therapeutic agent for vascular calcification. We investigated the effects of FGF21 on vascular smooth muscle cell (VSMC) calcification by culturing rat VSMCs in a calcifying medium for 9days. FGF21 markedly attenuated mineral deposition and apoptosis at the indicated time points. In the presence of FGF21, the expression levels of osteoblastic protein including bone morphogenic protein-2, alkaline phosphatase(ALP), runt-related transcription factor(RUNX)-2 and nuclear factor-kappa B ligand (RANKL) were down-regulated, whereas the expression of osteoprotegerin (OPG) increased. Knockdown of OPG significantly impaired inhibition of FGF21 on apoptosis and the expression of pro-apoptotic genes including caspase-3 and Bax and osteoblastic -promoting markers including ALP, RUNX-2 and RANKL. Furthermore, FGF21 facilitated the phosphoryl of AKT but suppressed P38, while OPG knockdown attenuated the effects. LY29400 (inhibitor of PI3K) abrogated the activation of PI3K/AKT and SB203580 (inhibitor of P38) abolished the inhibition of FGF21 on P38, while alteration was observed in the expression of RUNX-2. FGF21 inhibited VSMCs calcification via OPG/RANKL system, and through P38 andPI3K/AKT pathways.
Collapse
|
3
|
Vassalle C, Mazzone A. Bone loss and vascular calcification: A bi-directional interplay? Vascul Pharmacol 2016; 86:77-86. [DOI: 10.1016/j.vph.2016.07.003] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2015] [Revised: 06/22/2016] [Accepted: 07/01/2016] [Indexed: 02/07/2023]
|
4
|
Tomayko EJ, Cachia AJ, Chung HR, Wilund KR. Resveratrol supplementation reduces aortic atherosclerosis and calcification and attenuates loss of aerobic capacity in a mouse model of uremia. J Med Food 2014; 17:278-83. [PMID: 24476222 DOI: 10.1089/jmf.2012.0219] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
The polyphenolic compound resveratrol (RSV) has been studied for its protective effects on a variety of conditions, including cardiovascular disease (CVD), reduced exercise capacity, and bone disease. Individuals with chronic kidney disease suffer from a variety of these comorbid conditions, but the efficacy of RSV supplementation in this population is unknown. The objective of this study was to determine the efficacy of resveratrol feeding on factors related to CVD, aerobic capacity, and bone health in a mouse model of uremia. At 8 weeks of age, 28 female apolipoprotein E⁻/⁻ mice underwent a two-step surgical procedure to induce uremia and were randomized to one of the two treatment groups for 16 weeks: 0.04% w/w resveratrol supplemented diet (group designated as RSV) (n=12) or control diet (group designated as CON) (n=16). Cardiovascular risk was determined by analysis of aortic atherosclerotic lesion area and aortic calcium, aerobic capacity was measured by maximal oxygen consumption/maximal aerobic capacity (VO(₂max)) testing, and bone microarchitecture was assessed by microcomputed tomography. RSV animals had significantly fewer aortic atherosclerotic lesions at the site of the ascending aorta and lower aortic calcium at the branch of the coronary arteries compared with CON. Furthermore, there was a significant decline in VO(₂max) from baseline to final testing in the CON group, but VO(₂max) was preserved in the RSV group. Last, RSV had no significant effect on bone architecture. These data indicate that RSV supplementation improves vascular health and preserves aerobic capacity in a model of uremia, suggesting RSV supplementation could be examined as a therapeutic strategy for a critically ill population.
Collapse
Affiliation(s)
- Emily J Tomayko
- 1 Division of Nutritional Sciences, University of Illinois , Urbana-Champaign, Illinois, USA
| | | | | | | |
Collapse
|
5
|
GU SASA, ZHANG YAN, WU SHUYAN, DIAO TENGYUE, GEBRU YOSEPHASMELASH, DENG HONGWEN. Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice. Nephrology (Carlton) 2012; 17:767-73. [DOI: 10.1111/j.1440-1797.2012.01656.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
|